Plasma Osteopontin Level in Chronic Liver Disease and Hepatocellular Carcinoma.
BACKGROUND
Osteopontin (OPN) is a secreted glycoprotein and is frequently associated with various tumors.


OBJECTIVE
We sought to investigate the clinical usefulness of the level of plasma OPN, compared to α-fetoprotein (AFP), as a biomarker for hepatocellular carcinoma (HCC) and to evaluate its diagnostic value in nonalcoholic fatty liver disease (NAFLD) and its relationship with clinical and laboratory features of HCC and NAFLD.


METHODS
The study was performed on 120 subjects classified into 5 groups: Group I included 25 chronic non-cirrhotic hepatitis C virus (HCV)-infected patients; Group II encompassed 25 patients with chronic HCV infection with liver cirrhosis; Group III comprised 25 patients with chronic HCV with liver cirrhosis and HCC; Group IV was comprised of 25 patients with NAFLD; and Group V consisted of 20 healthy age- and sex-matched controls. All the participants were subjected to history taking and clinical and abdominal ultrasonographic examinations as well as the following laboratory investigations: liver function tests, complete blood count, blood sugar, hepatitis B surface antigen, hepatitis C virus antibodies, HCV-RNA by qualitative polymerase chain reaction (for Groups I, II, and III) and serum AFP and plasma OPN levels.


RESULTS
There were statistically significant differences in plasma OPN levels between the HCC group (401 ± 72 ng/mL) and the other groups, between the cirrhotic group (258.3 ± 35 ng/mL) and the non-cirrhotic group (HCV group, 168.7 ± 41 ng/mL; fatty liver group, 106.7 ± 35 ng/mL), and between the chronic non-cirrhotic HCV group and the fatty liver group (I and IV) and the controls (35.1 ± 6 ng/mL). In the HCC group, the diagnostic value of OPN was comparable to that of AFP at a cutoff value of 280 ng/mL, achieving sensitivity, specificity, and overall accuracy of 100%, 98%, and 96%, respectively. Regarding the validity of plasma OPN as a predictor of fatty change, our results revealed a diagnostic accuracy of 50% with 70% sensitivity, 45% specificity, 50% positive predictive value, and 75% negative predictive value at a cutoff value of 134 ng/mL.


CONCLUSIONS
Plasma OPN is comparable to AFP as a diagnostic marker and is related to the severity of liver involvement in HCC patients. Plasma OPN is of diagnostic potential value in NAFLD.
Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Shawky Abdelhamid
SA
Fouad
Department of Clinical and Chemical Pathology, National Research Center, Giza, Egypt.
Nagwa Abdel Ghaffar
NA
Mohamed
Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Mary Wadie
MW
Fawzy
Department of Internal Medicine, Faculty of Medicine, Cairo University, Cairo, Egypt.
Doaa Ali
DA
Moustafa
Fatty Liver; Hepatocellular Carcinoma; Osteopontin